Cargando…

Impact of Cardiovascular Risk Factors on the Occurrence of Cardiovascular Events in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitides

Despite improvement in the prognosis of ANCA-associated vasculitides (AAVs), increased mortality, mainly from a cardiovascular origin, persists. We aimed to determine the role of cardiovascular risk factors (CVRFs) on the occurrence of major cardiovascular events (MACEs) in AAVs. Patients with AAVs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roubille, Camille, Henriquez, Soledad, Mercuzot, Cédric, Duflos, Claire, Dunogue, Bertrand, Briot, Karine, Guillevin, Loic, Terrier, Benjamin, Fesler, Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198638/ https://www.ncbi.nlm.nih.gov/pubmed/34070514 http://dx.doi.org/10.3390/jcm10112299

Ejemplares similares

French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides)
por: Terrier, Benjamin, et al.
Publicado: (2020)

Correction to: French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides)
por: Terrier, Benjamin, et al.
Publicado: (2021)

Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides
por: Bonaci-Nikolic, Branka, et al.
Publicado: (2005)

CanVasc recommendations for the management of antineutrophil cytoplasm antibody (ANCA)-associated vasculitides – Executive summary
por: McGeoch, Lucy, et al.
Publicado: (2015)

Serum calprotectin and renal function decline in ANCA-associated vasculitides: a post hoc analysis of MAINRITSAN trial
por: Romand, Xavier, et al.
Publicado: (2023)

Presence of neutrophil extracellular traps and antineutrophil cytoplasmic antibodies associated with vasculitides
por: Abreu-Velez, Ana Maria, et al.
Publicado: (2009)

Olfactory dysfunction in antineutrophil cytoplasmic antibody-associated vasculitides: A review of the literature
por: Pendolino, Alfonso Luca, et al.
Publicado: (2021)

ANCA-associated vasculitides in childhood
por: Garan, Diána, et al.
Publicado: (2011)

Peripheral neuropathy in antineutrophil cytoplasmic antibody-associated vasculitides: Insights from the DCVAS study
por: Bischof, Antje, et al.
Publicado: (2019)

Antineutrophil cytoplasmic antibody associated vasculitides with renal involvement: Open challenges in the remission induction therapy
por: Salvadori, Maurizio, et al.
Publicado: (2018)

Virus-induced Systemic Vasculitides: New Therapeutic Approaches
por: Guillevin, Loïc
Publicado: (2004)

Overlap between dermatomyositis and ANCA vasculitides
por: Yuste, Claudia, et al.
Publicado: (2014)

The role of surgery in antineutrophil cytoplasmic antibody–associated vasculitides affecting the nose and sinuses: A systematic review
por: Pendolino, Alfonso Luca, et al.
Publicado: (2020)

Antineutrophil cytoplasmic antibodies (ANCA) – their role in pathogenesis, diagnosis, and treatment monitoring of ANCA-associated vasculitis
por: FIJOŁEK, JUSTYNA, et al.
Publicado: (2020)

Genetic loci of Staphylococcus aureus associated with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitides
por: Glasner, Corinna, et al.
Publicado: (2017)

Twenty-eight years with antineutrophil cytoplasmic antibodies (ANCA): how to test for ANCA — evidence-based immunology?
por: Csernok, Elena, et al.
Publicado: (2010)

Suspicion Is Key: Diagnosing Elusive Cytoplasmic Antineutrophil Cytoplasmic Antibody (c-ANCA)-Positive Vasculitis
por: Crowe, Timothy P, et al.
Publicado: (2022)

Microparticles expressing myeloperoxidase as potential biomarkers in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV)
por: Manojlovic, M., et al.
Publicado: (2020)

Subcutaneous Immunoglobulin for Antibody Deficiency in Antineutrophil Cytoplasmic Antibody (ANCA)-associated Vasculitis
por: Kant, Sam, et al.
Publicado: (2019)

Tofacitinib-Induced Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis With Crescentic Glomerulonephritis
por: Asemota, Uyioghosa, et al.
Publicado: (2021)

T-helper cells as new players in ANCA-associated vasculitides
por: Abdulahad, Wayel H, et al.
Publicado: (2011)

Development of an ANCA-Associated Vasculitides Patient Registry in Greece
por: Thomas, Konstantinos, et al.
Publicado: (2020)

The role of myeloperoxidase and myeloperoxidase–antineutrophil cytoplasmic antibodies (MPO-ANCAs) in the pathogenesis of human MPO-ANCA-associated glomerulonephritis
por: Arimura, Yoshihiro, et al.
Publicado: (2013)

Cytoplasmic Antineutrophil Cytoplasmic Antibodies (C-ANCA) Vasculitis: An Uncommon Complication After Stem Cell Transplantation
por: Raja, Ahmad, et al.
Publicado: (2022)

Limited Antineutrophil Cytoplasmic Antibodies (ANCA)-Negative Granulomatosis With Polyangiitis: Successful Response to Rituximab
por: Andrade, Maria Margarida, et al.
Publicado: (2023)

Therapeutic Complement Targeting in ANCA-Associated Vasculitides and Thrombotic Microangiopathy
por: Novikov, Pavel, et al.
Publicado: (2016)

Interest of Procalcitonin in ANCA Vasculitides for Differentiation between Flare and Infections
por: Poirot-Seynaeve, Xavier, et al.
Publicado: (2023)

Exploring Cardiovascular Manifestations in Vasculitides: An In-Depth Review
por: Vats, Vaibhav, et al.
Publicado: (2023)

A Case of Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis Post COVID-19 Vaccination
por: Al-Yafeai, Zaki, et al.
Publicado: (2022)

A Rare Case of Nephrotic-Range Proteinuria in Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis
por: Nasr, Rabih, et al.
Publicado: (2022)

Systematic Review and Metaanalysis of Worldwide Incidence and Prevalence of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis
por: Redondo-Rodriguez, Rocío, et al.
Publicado: (2022)

Antineutrophil Cytoplasmic Autoantibody (ANCA)-Associated Vasculitis With Mucosal Involvement Following COVID-19 Pneumonia
por: Ta, Hoang, et al.
Publicado: (2022)

Diagnostic significance of antineutrophil cytoplasmic antibody (ANCA) titres: a retrospective case-control study
por: Merindol, Julie, et al.
Publicado: (2023)

Antieosinophil Antibodies Alone or in Combination with Antineutrophil Cytoplasmic Antibodies (ANCA) Detected in Different Autoimmune Conditions
por: Dieckmann, Régis, et al.
Publicado: (2023)

Evaluation of Rituximab for Induction and Maintenance Therapy in Patients 75 Years and Older With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
por: Thietart, Sara, et al.
Publicado: (2022)

Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis
por: Thompson, Gwen E., et al.
Publicado: (2020)

Hydralazine-Induced Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: A Case Report and Literature Review
por: Alawneh, Diala, et al.
Publicado: (2022)

A RARE CASE OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA)-ASSOCIATED VASCULITIS IN THE SETTING OF COVID-19 INFECTION
por: RATH, PALAK, et al.
Publicado: (2022)

Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV) Masquerading As Mononeuritis Multiplex: A Case Report
por: Patel, Anandkumar, et al.
Publicado: (2023)

Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis developed from ANCA negative renal limited vasculitis: A case report
por: Li, Xiao-li, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6dnsqobfd2tijmltse9mog2o68